½ÃÀ庸°í¼­
»óǰÄÚµå
1448022

¼¼°èÀÇ ³­°¢¸· À¯µµÃ¼ ½ÃÀå(2023-2030³â)

Eggshell Membrane Derivatives Market - 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 210 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°³¿ä

³­°¢¸· À¯µµÃ¼ ¼¼°è ½ÃÀåÀº 2022³â 7¾ï 8,910¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.8% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 13¾ï 3,567¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³­°¢¸· À¯µµÃ¼´Â ´Ü¹éÁú, Äݶó°Õ, ±Û¸®ÄÚ»ç¹Ì³ë±Û¸®Ä­, ¿¤¶ó½ºÆ¾ ¹× ±âŸ Çʼö ¿µ¾ç¼Ò¸¦ dzºÎÇÏ°Ô ÇÔÀ¯Çϰí ÀÖ¾î ´Ù¾çÇÑ ÀǾàǰ, °Ç°­ º¸Á¶ ½Äǰ ¹× È­Àåǰ »ê¾÷¿¡¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ³­°¢¸· À¯µµÃ¼ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ³­°¢¸· À¯µµÃ¼ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ´Ù¾çÇÑ »ê¾÷ ºÐ¾ßÀÇ Á¦Á¶¾÷üµéÀÌ ³­°¢¸·À» Çõ½ÅÀûÀ¸·Î °³¹ßÇÏ¿© Æ÷Æ®Æú¸®¿À¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 10¿ù, ¾Ø¼¾Æ® ´ºÆ®¸®¼Ç(Ancient Nutrition)Àº »õ·Î¿î Äݶó°Õ ÆéŸÀÌµå ¶óÀÎÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÆéŸÀ̵å´Â °Ç°­ÇÑ ¸ð¹ß, ÇǺÎ, ¼ÕÅé, °üÀý, Àå °Ç°­À» Áö¿øÇÏ´Â ¹ßÈ¿ ³­°¢¸· ÆéŸÀ̵åÀÔ´Ï´Ù. ÀÌ ÆéŸÀ̵å´Â ¶ÇÇÑ ±î¸¶±Í ¹ßÀÚ±¹À» °³¼±Çϰí, °üÀýÀÇ ºÒÆíÇÔÀ» ÁÙÀ̰í, °üÀý ȸº¹À» ÃËÁøÇϰí, Äݶó°Õ ºÐÇØ¸¦ ¾ïÁ¦ÇÕ´Ï´Ù.

³­°¢¸· ÃßÃâ¹°·Î ¸¸µç ĸ½¶Àº ³­°¢¸· À¯µµÃ¼ ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, À¯·´ Áö¿ªÀÌ ¼¼°è Á¡À¯À²¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ½À´Ï´Ù.

´ÙÀ̳ª¹Í½º

°üÀýÅë Ä¡·á¿¡¼­ ³­°¢¸· À¯µµÃ¼¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Á¦¾à ¾÷°è¿¡¼­´Â ÇÕ¼º ¼ººÐÀÇ ´ëüǰÀ¸·Î ³­°¢¸· À¯µµÃ¼°¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À¯µµÃ¼¿¡´Â Äݶó°Õ, ±Û·çÄÚ»ç¹Î, Äܵå·ÎÀÌÆ¾, È÷¾Ë·ç·Ð»ê°ú °°Àº À¯ÀÍÇÑ È­ÇÕ¹°ÀÌ Æ÷ÇԵǾî ÀÖ¾î °üÀý Á¶Á÷ÀÇ À¯Áö¿Í ȸº¹¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î °ñ°üÀý¿°°ú °°Àº Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ±¹¸³ÀÇÇеµ¼­°üÀÇ º¸°í¿¡ µû¸£¸é, õ¿¬ ³­°¢¸·(NEM)Àº ¹«¸­ °üÀý¿°À¸·Î ÀÎÇÑ ÅëÁõ°ú »»»»ÇÔÀ» Ä¡·áÇÏ´Â µ¥ È¿°úÀûÀÌ°í ¾ÈÀüÇÑ ´ë¾ÈÀ¸·Î, ÇÏ·ç 1ȸ 500mgÀÇ NEMÀ» º¹¿ëÇϸé 10ÀÏ, 30ÀÏ, 60ÀÏ ÈÄ °üÀý ÅëÁõ°ú »»»»ÇÔÀÌ À§¾à¿¡ ºñÇØ À¯ÀÇÇÏ°Ô °¨¼ÒÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù°í ÇÕ´Ï´Ù.

³­°¢¸·ÀÇ È¿´É¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü

³­°¢¸·ÀÇ È¿´É¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼¼°è ³­°¢¸· ÃßÃâ¹° ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ³­°¢¸·¿¡´Â Äݶó°Õ, ±Û·çÄÚ»ç¹Î µî °üÀý °Ç°­¿¡ ÇʼöÀûÀΠõ¿¬ ¼ººÐÀÌ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ä®½· ¹× ±âŸ ¹Ì³×¶ö°ú °°Àº Çʼö ¿µ¾ç¼Ò¸¦ ÇÔÀ¯Çϰí ÀÖ¾î Àü¹ÝÀûÀÎ »À °Ç°­¿¡ ±â¿©ÇÕ´Ï´Ù.

¶ÇÇÑ, ¸¹Àº Á¦Á¶È¸»çµéÀÌ Á¦Ç°À» Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ½ºÆ®·¡ÅÒ ´ºÆ®¸®¼Ç(Stratum Nutrition)ÀÇ NEMÀº Àç»ý °¡´ÉÇÑ ¹Ì±¹»ê ´Þ°¿ ²®ÁúÀ» ¿ø·á·Î ÇÕ´Ï´Ù. ÅëÁõ, »»»»ÇÔ, ¿¬°ñ ÆÄ±«¿¡ ´ëÇØ ´Ü 4-11ÀÏ ¸¸¿¡ °Ç°­ÇÑ °üÀýÀ» Áö¿øÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ Á¦Ç° Çõ½ÅÀ» ÅëÇØ ´õ ³ôÀº ¼ö¿ë·ü°ú »ç¿ë·ü¿¡ ±â¿©ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ºñ°Ç Æ®·»µå°¡ È®»ê

¿¹¸¦ µé¾î, ¼¼°èµ¿¹°Àç´Ü(World Animal Foundation)ÀÇ Ãֽе¥ÀÌÅÍ¿¡ µû¸£¸é 2023³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 8,800¸¸ ¸íÀÇ ºñ°Ç ä½ÄÁÖÀÇÀÚ°¡ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºñ°Ç ä½ÄÁÖÀÇ¿Í ºñ°Ç ä½ÄÁÖÀÇ Æ®·»µå°¡ Å©°Ô Áõ°¡Çϰí ÀÖ´Ù°í ÇÕ´Ï´Ù. ³­°¢¸· À¯µµÃ¼´Â ´ëºÎºÐ µ¿¹°¼º ¿ø·á·Î ¸¸µé¾îÁö±â ¶§¹®¿¡ ºñ°Ç Àα¸ÀÇ Áõ°¡´Â º¸±Þ·ü¿¡ ¿µÇâÀ» ¹ÌÃÄ ½ÃÀå ¼ºÀå·ü Ç϶ôÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °üÀýÅë Ä¡·á¿ë ³­°¢¸· À¯µµÃ¼¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • ³­°¢¸·ÀÇ ÀÌÁ¡¿¡ °üÇÑ ¼ÒºñÀÚ ÀÎ½Ä È®»ê
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • ä½ÄÁÖÀÇÀÚ µ¿Çâ »ó½Â
    • ±âȸ
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ºÐ¼®
  • DMIÀÇ °ßÇØ

Á¦6Àå COVID-19 ºÐ¼®

Á¦7Àå Á¦Ç° Çüź°

  • ºÐ¸»
  • ³óÃà
  • ĸ½¶
  • ±âŸ

Á¦8Àå Æ÷À庰

  • º¸Æ²
  • ÆÄ¿ìÄ¡
  • ±âŸ

Á¦9Àå À¯Åë ä³Îº°

  • ÇÏÀÌÆÛ¸¶ÄÏ/½´ÆÛ¸¶ÄÏ
  • Àü¹®Á¡
  • ±âŸ

Á¦10Àå ¿ëµµº°

  • ´ºÆ®¶ó½´Æ¼ÄÃ
  • ½Äǰ¡¤À½·á
  • È­Àåǰ¡¤ÆÛ½º³ÎÄɾî
  • ±âŸ

Á¦11Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå °æÀï »óȲ

  • °æÀï ½Ã³ª¸®¿À
  • ½ÃÀå »óȲ/Á¡À¯À² ºÐ¼®
  • M&A ºÐ¼®

Á¦13Àå ±â¾÷ °³¿ä

  • Biova LLC
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • Kewpie Corporation
  • Microcore.
  • Bolise Co., Ltd.
  • Certified Nutraceuticals Inc.
  • Ecovatec Solutions Inc.
  • EGGBRANE
  • Eggnovo
  • Stratum Nutrition
  • NOW Health Group, Inc.

Á¦14Àå ºÎ·Ï

ksm 24.04.01

Overview

Global Eggshell Membrane Derivatives Market reached US$ 789.1 million in 2022 and is expected to reach US$ 1335.67 million by 2030, growing with a CAGR of 6.8% during the forecast period 2023-2030.

The demand for eggshell membrane derivatives is rising among various pharmaceuticals, nutraceuticals, and cosmetics industries as these derivatives are rich in proteins, collagen, glycosaminoglycans, elastin, and other essential nutrients, which contributes to the growth of the global eggshell membrane derivatives market.

Furthermore, as the demand for eggshell membrane derivates products is rising, manufacturers of various industries are innovatively developing and incorporating the eggshell membrane in their portfolios. For instance, in October 2021, Ancient Nutrition launched a new line of collagen peptides. they are fermented eggshell membranes, that help to support healthy hair, skin, nails, joints, and gut. The peptides also improve the appearance of crow's feet, reduce joint discomfort, help joints recover faster, and reduce collagen degradation

The capsules made of eggshell membrane extracts account for the largest share in the global egg shell membrane derivatives market, as well as European region shows dominance in the world share, as the manufacturing companies in this region are strategically planning for developing and expanding the products in this region.

Dynamics

Increasing Demand for Eggshell Membrane Derivates for Joint Pain Treatment

The pharmaceutical industry is increasingly using eggshell membrane derivatives as a substitute for synthetic ingredients. These derivatives contain beneficial compounds, such as collagen, glucosamine, chondroitin, and hyaluronic acid, which may aid in the maintenance and repair of joint tissues. As a result, they can help alleviate symptoms associated with conditions like osteoarthritis.

In addition, according to the National Library of Medicine report, Natural Eggshell Membrane (NEM) is an effective and safe option for the treatment of pain and stiffness associated with knee osteoarthritis. Supplementation with NEM, 500 mg taken once daily, significantly reduced both joint pain and stiffness compared to placebo at 10, 30, and 60 days.

Rising Consumer Awareness About the Benefits of Eggshell Membrane

The rising consumer awareness about the benefits of eggshell membranes is significantly driving the global eggshell membrane extract market. They have natural compounds such as collagen, glucosamine, and others which are essential for joint health. They also contain essential nutrients like calcium and other minerals, which contribute to overall bone health.

Furthermore, many manufacturing companies are launching products in their portfolios. For instance, Stratum Nutrition company produces NEM is sustainably sourced from a renewable supply of US-domestic eggshells. It helps support healthy joints against pain, stiffness, and cartilage breakdown in as little as 4-11 days. Hence, implementing such product innovations can contribute to a higher rate of acceptance and usage.

Rising in Vegan Trend

Veganism and vegan trends are rising significantly, for instance, according to the World Animal Foundation's most recent data of 2023,88 million vegans in the world. As eggshell derivatives are often sourced from animals, the rising vegan population can affect the adoption rate and cause a decline in market growth.

Segment Analysis

The global Eggshell Membrane Derivatives market is segmented based on product form, packaging, distribution channel, application, and region.

Rising Demand for Eggshell Membrane Derivatives Capsules

The capsules segment accounts for the maximum share of the global eggshell membrane derivatives market. Consumers are highly adopting these capsules as dietary supplements as they contain collagen, calcium, glucosamine, and others as major components, which help in reducing joint pains and maintaining bone health.

Furthermore, Manufacturing companies are currently developing innovative products by utilizing the eggshell membrane. For instance, NOW Health Group, Inc. has developed Eggshell Membrane 500 mg Capsules NEM can help maintain healthy articular cartilage and surrounding synovial tissue by nourishing joints and supporting a balanced immune response to typical daily wear and tear. NEM can help to promote normal joint comfort and flexibility, usually within 7-10 days.

Geographical Penetration

Manufacturing Companies Partnerships

Europe has been a dominant force in the global eggshell membrane derivatives market and its significance has only grown in the post-2020 era. Consumers in this region are adopting these eggshell membrane extracts for various pharmaceutical applications, as they offer natural collagen and others.

Furthermore, manufacturing companies are strategically planning on expanding their market sizes, for instance, in January 2024, Bioiberica partnered with Faes Farma in Spain for a finished supplement called Vitanatur Multicollagen. This formula combines 40 mg of Collavant n2, along with eggshell membrane, which contains types I, V, and X collagen, hyaluronic acid, magnesium, and vitamins C, K2, and D3, for joint, bone, and skin health support.

Competitive Landscape

The major global players in the market include Biova LLC, Kewpie Corporation, Microcore., Bolise Co., Ltd., Certified Nutraceuticals Inc., Ecovatec Solutions Inc., EGGBRANE, Eggnovo, Stratum Nutrition, and NOW Health Group, Inc.

COVID-19 Impact Analysis

The production and processing of eggshell membrane derivatives has been halted due to COVID-19 implications. This has resulted in a decrease in stock production, causing a reduction in the industry's revenue. The supply chain has been disrupted due to a lack of transportation of raw materials and goods, leading to a mismatch between market demand and supply. As a result, consumers are unable to receive the goods, which has severely impacted the firm's revenue.

By Product Form

  • Powder
  • Concentrated
  • Capsules
  • Others

By Packaging

  • Bottles
  • Pouches
  • Others

By Distribution Channel

  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Others

By Application

  • Nutraceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In November 2023, Hardeman Egg Group acquired egg processing and trading company Egga Food Group including egg dying company Eivo. With this acquisition, Hardeman Egg Group intends to strengthen its international market position.
  • In October 2023, Cal-Maine Foods, Inc. acquired all the assets of Fassio Egg Farms, Inc., related to its commercial shell egg production and processing business. The acquired assets include commercial shell egg production and processing facilities with a current capacity of approximately 1.2 million laying hens, and others.
  • In April 2022, the Ready Egg Group acquired Skea Egg Farms Ltd. The acquisition of Skea Egg Farms Ltd has allowed for further diversification in the group, cementing its position as a leading player in the market.

Why Purchase the Report?

  • To visualize the global eggshell membrane derivatives market segmentation based on product form, packaging, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of eggshell membrane derivatives market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global eggshell membrane derivatives market report would provide approximately 70 tables, 64 figures, and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product Form
  • 3.2.Snippet by Packaging
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Demand for Eggshell Membrane Derivates for Joint Pain Treatment
      • 4.1.1.2. Rising Consumer Awareness About the Benefits of Eggshell Membrane
    • 4.1.2.Restraints
      • 4.1.2.1.Rising in Vegan Trend
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product Form

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 7.1.2.Market Attractiveness Index, By Product Form
  • 7.2.Powder*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Concentrated
  • 7.4.Capsules
  • 7.5.Others

8.By Packaging

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 8.1.2.Market Attractiveness Index, By Packaging
  • 8.2.Bottles*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Pouches
  • 8.4.Others

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Hypermarkets/Supermarkets*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Specialty Stores
  • 9.4.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Nutraceuticals*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Food & Beverages
  • 10.4.Cosmetics & Personal Care
  • 10.5.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Biova LLC*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Kewpie Corporation
  • 13.3.Microcore.
  • 13.4.Bolise Co., Ltd.
  • 13.5.Certified Nutraceuticals Inc.
  • 13.6.Ecovatec Solutions Inc.
  • 13.7.EGGBRANE
  • 13.8.Eggnovo
  • 13.9.Stratum Nutrition
  • 13.10.NOW Health Group, Inc.

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦